Resource Center
Resource Center
CHAI is pleased to release the 10th issue of our annual HIV Market Report: The state of HIV treatment, testing, and prevention in low- and middle-income countries. The report provides a detailed look at the complex, ever-changing antiretroviral (ARV) and diagnostic markets in low- and middle-income countries based on aggregated market intelligence from our programmatic work...
Read moreSince launching its viral hepatitis program, Rwanda has taken an aggressive approach to combating the disease. By the end of 2018, around 700,000 people were screened for HCV and 10,000 treated and cured.
Read moreA clear understanding of the complex, ever-changing antiretroviral (ARV) and diagnostic markets in low- and middle-income countries is critical for all stakeholders in the HIV space. To address this need, CHAI publishes an annual HIV market report for public consumption based on aggregated market intelligence from our programmatic work in over 30 countries. We are...
Read moreAfter five hours hunched in a crowded minibus, three hours trying to soothe a crying baby, and one hour waiting to see a healthcare worker, she had made it. This Malawian mother had finally made it to a health facility to test her baby for HIV. Despite the hours of travel, she soon learned that...
Read moreAmsterdam – A breakthrough pricing agreement will significantly reduce the cost of diagnostic testing for HIV/AIDS, hepatitis and cervical cancer for millions of people in low- and middle-income countries. Diagnostic testing improves patient care, helps prevent the spread of disease, and reduces healthcare spending. The new agreement, announced today at the 2018 International AIDS Conference,...
Read moreWe are delighted to announce the joint launch of a partnership to speed up development and introduction of optimized pediatric formulations of dolutegravir for children living with HIV in resource-limited settings. The new initiative includes an incentive program and is a key feature of Unitaid’s US$34 million Optimal Antiretroviral (ARV) grant to CHAI. The optimal...
Read moreIn 2013, Uganda introduced an HIV test-and-treat policy into its national healthcare guidelines, as recommended by the World Health Organization. This provided all people under the age of 15 with antiretroviral therapy (ART) immediately after their HIV positive status was confirmed. With the new policy, the country saw a nearly 50 percent increase in the...
Read moreCHAI supports national governments to expand high-quality care and treatment to people living with HIV/AIDS. CHAI negotiates reduced prices for antiretroviral (ARVs) on behalf of members of its procurement consortium. See the 2017 CHAI ARV Reference Price List here.
Read moreI joined CHAI as a volunteer in February 2003. I had just graduated with a Master’s degree in economics from the London School of Economics and returned home to Kenya. While on the job hunt, a friend of mine volunteering with CHAI from McKinsey and Company asked if I would be interested in joining their...
Read moreThis World AIDS Day, we celebrate the tremendous progress that has been made in response to the HIV/AIDS epidemic, with more than 20 million people living with HIV accessing life-saving antiretroviral treatment (ART) as of today. The incredible scale up of ART in developing countries, with affordable generic drugs widely available and the majority of...
Read more